Syndrome News and Research

RSS

Birth abnormality rates could increase if proposed changes to prenatal testing go ahead

A proposed change to the type of prenatal genetic testing offered to couples in the UK could result in certain chromosome abnormalities being missed, suggests a study published online today (Thursday June 30, 2005) by The Lancet.

1 Jul 2005

Preclinical data suggest CuraGen's Velafermin may protect the gastrointestinal tract and decrease associated toxicity following exposure to radiation

New preclinical data on velafermin (CG53135), CuraGen's Phase II clinical product being developed for the prevention of oral mucositis (OM), suggesting that velafermin may protect the gastrointestinal tract and decrease associated toxicity, including enteritis and diarrhea, following exposure to radiation.

1 Jul 2005

New initiative to provide $600k to fund new research into Down Syndrome

Today the University of Colorado and The Anna and John J. Sie Foundation of Denver announced The Sie Family Down Syndrome Break-Through Research Initiative. The initiative will provide $600,000 in grant funds to stimulate new scientific research on Down syndrome with the aim of enhancing cognitive ability. These are the first such grants provided to CU for a specific chromosomal condition and the first nationwide specifically for Down syndrome.

1 Jul 2005

Undetected autism in women manifests as anorexia nervosa

According to a leading expert, severe cases of anorexia may be the result of undetected autism in women.

30 Jun 2005

Europe tackles pre-diabetes

Diabetes is the fourth leading global cause of death and, with over 60 million people in Europe already estimated to have pre-diabetes, the situation is set to escalate at an alarming rate unless urgent action is taken.

29 Jun 2005

Pregnancy and birth factors may determine likelihood of polycystic ovarian syndrome

New research suggests that the way baby girls develop in the womb may affect whether or not they develop polycystic ovarian syndrome (PCOS) as adults and the severity of the symptoms if they do.

27 Jun 2005

Determining prognosis in patients with chest pain now easier and more accurate

A new, more precise test is available to improve the accuracy of detecting coronary artery disease and risk of heart attack, and can be done right at the bedside.

22 Jun 2005

New insight into autoimmune disease

The immune system is a complex and powerful weapon that provides protection against bacteria and viruses that, if left unchecked, would wreak havoc throughout the human body.

21 Jun 2005

Effect of new Italian law on the choices available to infertile parents

Three presentations to the '21st annual conference of the European Society of Human Reproduction and Embryology highlighted the effect of the new Italian law on the choices available to infertile parents.

21 Jun 2005

Fragile-X-syndrome research

The fragile-X-syndrome is the most common hereditary form of mental retardation and occurs much more often in boys than in girls.

20 Jun 2005

Drug for schizophrenia can prevent and treat SARS

Chinese and European experts at a conference of the Sino-European Project on SARS Diagnostics and Antivirals in China say that a drug normally used to treat schizophrenia has been shown to prevent and treat Severe Acute Respiratory Syndrome (SARS).

20 Jun 2005

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.

16 Jun 2005

Immunomedics awarded U.S. and Australian patents

Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.

16 Jun 2005

Vical receives $12 Million HIV vaccine order

Vical Incorporated announced today the receipt of approximately $12.1 million in production orders for multiple clinical lots of DNA vaccines against HIV for the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, under a subcontract managed by SAIC-Frederick, Inc.

16 Jun 2005

Protocol used to treat the first known survivor of rabies without prior vaccination published

The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.

15 Jun 2005